WHO monographs on selected medicinal plants - travolekar.ru

<strong>WHO</strong> <strong>monographs</strong> on selected medicinal plants
16. Mian E et al. Antocianosidi e parete dei microvasi nuovi aspetti sul modo
d’azione dell’effetto protettivo nelle sindromi da absorme fragilitá capillare
[Anthocyanosides and the walls of the microvessels: further aspects of the
mechanism of action of their protective effect in syndromes due to abnormal
capillary fragility]. Minerva Medica, 1997, 68:3565–3581 [in Italian].
17. Bravetti G. Preventive medical treatment of senile cataract with vitamin E
and anthocyanosides: clinical evaluation. Annali di Ottalmologia e Clinica
Oculistica, 1989, 115:109.
18. Head K. Natural therapies for ocular disorders part two: cataracts and glaucoma.
Alternative Medicine Review, 2001, 6:141–166.
19. Perossini M et al. Diabetic and hypertensive retinopathy therapy with Vaccinium
myrtillus anthocyanosides (Tegens): Double-blind placebo controlled
clinical trial. Annali di Ottalmologia e Clinica Oculistica, 1987, 113:1173 [in
Italian].
20. Blumenthal M et al., eds. The complete German Commission E <strong>monographs</strong>:
therapeutic guide to herbal medicines. Austin, TX, American Botanical
Council, 1998.
21. Lietti A, Cristoni A, Picci M. Studies on Vaccinium myrtillus anthocyanosides.
I. Vasoprotective and antiinflammatory activity. Arzneimittel-Forschung,
1976, 26:829–832.
22. Laplaud PM, Lelubre A, Chapman MJ. Antioxidant action of Vaccinium
myrtillus extract on human low density lipoproteins in vitro: initial observations.
Fundamental & Clinical Pharmacology, 1997, 11:35–40.
23. Martín-Aragón S et al. Antioxidant action of Vaccinium myrtillus L. Phytotherapy
Research, 1998, 12:S104–S106.
24. Prior RL et al. Antioxidant capacity as influenced by total phenolic and anthocyanin
content, maturity, and variety of Vaccinium species. Journal of Agricultural
and Food Chemistry, 1998, 46:2686–2693.
25. Wasek M et al. Electron spin resonance assessment of the antioxidant potential
of medicinal plants. Part I. Contribution of anthocyanosides and flavonoids
to the radical scavenging ability of fruit and herbal teas. Acta Polaniae
Pharmaceutica, 2001, 58:283–288.
26. Lietti A, Forni G. Studies on Vaccinium myrtillus anthocyanosides. II. Aspects
of anthocyanins pharmacokinetics in the rat. Arzneimittel-Forschung,
1976, 26:832–835.
27. Eandi M. Post-marketing investigation on Tegens preparation with respect
to side effects. 1987. Cited in Morazzoni P, Bombardelli E. Vaccinium myrtillus
I. Fitoterapia, 1996, 67:3–29.
28. Detre Z et al. Studies on vascular permeability in hypertension: Action of
anthocyanosides. Clinical Physiology and Biochemistry, 1986, 4:143–149.
29. Kadar A et al. Influence of anthocyanoside treatment on the cholesterolinduced
atherosclerosis in the rabbit. Paroi Arterielle, 1979, 5:187–205.
30. Cohen-Boulakia F et al. In vivo sequential study of skeletal muscle capillary
permeability in diabetic rats: effect of anthocyanosides. Metabolism, 2000,
49:880–885.
224